Brian Granda
10Patents
2h-index
50Co-inventors
49Inventor score
Filing activity: Dec 19, 2014 → Jan 5, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10287354B2 | Regulatable chimeric antigen receptor | Chemistry; Metallurgy | 21 | Active |
| US10525083B2 | Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain | Chemistry; Metallurgy | 9 | Active |
| US11026976B2 | Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain | Chemistry; Metallurgy | 2 | Active |
| US12037378B2 | Variant CD58 domains and uses thereof | Chemistry; Metallurgy | 0 | Active |
| USRE49847E1 | Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain | General | 0 | Active |
| US12221481B2 | CD19 binding molecules and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11872249B2 | Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain | Chemistry; Metallurgy | 0 | Active |
| US11667691B2 | Treatment of cancer using chimeric CD3 receptor proteins | Chemistry; Metallurgy | 0 | Active |
| US11578130B2 | Regulatable chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US12383601B2 | Chimeric antigen receptors and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.